COVID-19 Coronavirus

Pfizer Inc (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA (mRNA) technology. The small biotechnology firm claims that its...

Novavax Inc's (NASDAQ: NVAX) R&D chief Filip Dubovsky expressed confidence that the company's updated COVID-19 vaccine, already in production, will offer protection against the rapidly emerging coronavirus variants prevalent in the U.S. Novavax's protein-based vaccines,...

In an annual general meeting, BioNTech SE's (NASDAQ: BNTX) CEO and co-founder Ugur Sahin told shareholders the company is working on COVID-19 vaccines targeting XBB.1.5 strains in line with recommendations by the World Health Organization. Last week, an advisory group for the World...

GeoVax Labs Inc (NASDAQ: GOVX) announced the presentation of updates on developing its next-generation COVID-19 vaccine, GEO-CM04S1, including preliminary data from an ongoing Phase 2 trial. The data were presented at the Vaccines Summit Boston 2023 and the Congress for the International...

An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the upcoming winter season. The shots currently used in the U.K. and U.S. target the original omicron strain, to which the XBB.1.5 or XBB.1...

The European Union bloc is reportedly negotiating an amended deal with Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) for around 70 million COVID-19 vaccine doses, despite the European public prosecutor opening a criminal investigation into their original agreement....

AstraZeneca plc's (NASDAQ: AZN) vaccine head highlighted the confidence that the company's new COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants. Laboratory studies show that the antibody, dubbed AZD3152, neutralizes all known...

On Tuesday, the FDA amended the emergency use authorizations (EUAs) of Moderna Inc (NASDAQ: MRNA) and Pfizer Inc (NYSE: PFE), and BioNTech SE's (NASDAQ: BNTX) COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule.  This action...

Axcella Health Inc (NASDAQ: AXLA) is reportedly looking for funding to support its advanced trial of a drug initially found to improve fatigue in long Covid patients. An early-stage trial of the drug, dubbed AXA1125, with the University of Oxford, found that participants given the treatment...

Tiziana Life Sciences Ltd (NASDAQ: TLSA) plans to investigate intranasal foralumab for Long COVID. What Happened: The work is supported by foralumab's well-established role in de-activating microglia cells, a key component in this disease's pathogenesis. "We anticipate...

A U.S. appeals court affirmed a decision to cancel an Arbutus Biopharma Corporation (NASDAQ: ABUS) patent related to a legal fight over Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccines. The U.S. Court of Appeals for the Federal Circuit upheld a U.S. Patent and Trademark...

The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a Biden administration official said. The investment, "Project NextGen," first announced by...

InflaRx NV's (NASDAQ: IFRX) stock is up Wednesday morning as the FDA granted emergency-use authorization to its monoclonal antibody for hospitalized COVID patients when initiated within 48 hours of receiving artificial life support. Vilobelimab, which will be sold under Gohibic...

Arbutus Biopharma Corporation (NASDAQ: ABUS) and its licensee Genevant Sciences have sued Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) in the U.S. District Court for the District of New Jersey, seeking damages for infringement of five U....

Pfizer Inc (NYSE: PFE) and Merck & Co Inc (NYSE: MRK) have reportedly lowered the prices of their respective COVID-19 treatments in China. Pfizer cut the price of Paxlovid by about 100 yuan ($14.54) to 1,790 yuan per box of 30 pills, while Merck marginally lowered the price of a...